Stock SCPH SCPHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News scPharmaceuticals Inc.

Equities

SCPH

US8106481059

Real-time Estimate Cboe BZX
Other stock markets
 01:07:12 2024-04-29 pm EDT 		5-day change 1st Jan Change
4.6 USD +2.45% Intraday chart for scPharmaceuticals Inc. +1.42% -26.08%
Apr. 24 ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection CI
Mar. 13 Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector Injection
AQ
ScPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection
AQ
ScPharmaceuticals Inc. Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of Furoscix Auto-Injector (Furosemide 80Mg/Ml) Injection
CI
Transcript : ScPharmaceuticals Inc., Q4 2023 Earnings Call, Mar 13, 2024
ScPharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
ScPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
AQ
ScPharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
ScPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024
AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences
AQ
ScPharmaceuticals Expects Higher Q4 Product Sales
MT
ScPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue
AQ
ScPharmaceuticals Inc. Provides Revenue Guidance for the Full Year 2023
CI
Transcript : ScPharmaceuticals Inc., Q3 2023 Earnings Call, Nov 08, 2023
ScPharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
ScPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
AQ
ScPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
AQ
ScPharmaceuticals to Participate in Two Upcoming Investor Conferences
AQ
ScPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
ScPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives
AQ
Scpharmaceuticals Announces Positive Feedback from Two Fda Meetings on Key Long-Term Growth Initiatives
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SCPH Stock
  4. News scPharmaceuticals Inc.